Genetic Engineering & Biotechnology News reports on growing use ...

Courtesy EurekAlert! - Chemistry, Physics and Materials Sciences  Tue, 04/15/2008 - 22:00

Biotech and pharma companies are increasingly relying on cell-based assays in early drug discovery work, reports Genetic Engineering & Biotechnology News.

The technique can provide a quick and lower cost means of testing drug candidates for toxic effects, according to an article in the April 15 issue of GEN.

Tags:

 

More related items

A Computational Framework for Systems-based Analysis...
Discusses the EPA/NCCT ToxRefDB database. The EPA is building capacity for multi-dimensional evaluation of toxicity using information aboout chemical properties, genome-wide responses, and...

EPA'S TOXCAST PROGRAM FOR PREDICTING TOXICITY AND...
ToxCast is a research program to predict or forecast toxicity by evaluating a broad spectrum of chemicals and effects; physical-chemical properties, predicted bioactivities, HTS and...

EPA Project Updates: DSSTox and ToxCast Generating...
EPA's National Center for Computational Toxicology is building capabilities to support a new paradigm for toxicity screening and prediction. The DSSTox project is improving public access to...

HP 50g Graphing Calculator (F2229AA#ABA)
If you're a math, science, or engineering professional?or a serious college student?don't leave home without it! HP's most powerful new graphing calculator. The 50G supplies you with...

Kitchen Mysteries: Revealing the Science of Cooking...
An international celebrity and founder of molecular gastronomy, or the scientific investigation of culinary practice, Herv& eacute; This is known for his ground-breaking research into the...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com